|
|
 |
|
Viewing report
|
|
|
|
Bapineuzumab Phase 2 Clinical Trial Results Call - Wyeth,Elan Corp. Plc, - Earnings Transcript
FactSet, July 2008
Bapineuzumab Phase 2 Clinical Trial Results Call - Wyeth,Elan Corp. Plc, - Earnings Transcript
Tuesday, July 29, 2008 11:00
Corrected Transcripts are verbatim transcripts that have been reviewed and corrected by industry-focused financial professionals. Our editors re-listen to the entire call audio and confirm and research all the terms and numbers in the call to eliminate 'inaudible,' 'indiscernible,' or 'phonetic' entries. The result is the most accurate Corrected Transcript available in the marketplace.
Coverage of a variety of event types:
- Analyst/Shareholder Meetings
- Conferences and Presentations
- Earnings
- Guidance/Update Meetings
- Sales Results
- Special Events and M&A
Product samples
Samples for this product is available. Please Login/Register to download these samples.
 - Wyeth RSS Feed.
Customers who bought this item also bought
Bapineuzumab Phase 2 Clinical Trial Results Call - Wyeth,Elan Corp. Plc, - Earnings Transcript
Prospects for the Phase III Bapineuzumab Trial
CR011-vcMMAE Phase II Clinical Trial Results Call - CuraGen Corp., - Earnings Transcript
Adipiplon Phase 2/3 Clinical Trial Results Call - Neurogen Corp., - Earnings Transcript
CK-1827452 Phase IIa Clinical Trial Results Call - - Earnings Transcript
INCB18424 Phase IIa Clinical Trial Results Call - - Earnings Transcript
ICH Phase 3 Clinical Trial Results Call - Novo-Nordisk A/S - Earnings Transcript
PROVENGE IMPACT Phase III Clinical Trial Results Call - Dendreon Corp., - Earnings Transcript
Elagolix PETAL Phase II Clinical Trial Results Call - - Earnings Transcript
AV650 Phase 2b Clinical Trial Results Call - Avigen, Inc., - Earnings Transcript
TNFerade Phase III Clinical Trial Results Call - GenVec, Inc., - Earnings Transcript
Albuferon(R) Phase 3 Clinical Trial Results Call - - Earnings Transcript
|
|
|
|
